Crown BioScience
PreClinOmics    简体    繁体   ENGLISH
Search Google
  • About
    • Company
    • What we do
    • Leadership team
    • Investors
    • Scientific advisors
    • Strategic Partners
    • Careers
  • Oncology
    • Oncology databases
    • Ex vivo services
    • Human surrogate trials
    • In vitro services
    • In vivo services
    • Preclinical Formulations
    • Translational Research
    • Drug Discovery Services
  • Metabolic Disease
    • In vivo services
    • In vitro services
    • PreClinOmics
    • Ex vivo services
    • Translational research
    • Drug discovery services
  • Products
    • Antibodies
    • Tissues
    • Proteins
    • Cell Lines
    • Tumor Samples
  • News
    • Blog
    • Events
    • Press
  • Publications
    • FAQs
    • Fact sheets
    • Presentations
    • Whitepapers
    • Posters
  • Contact us
crownbio-hero-oncology.jpg

    THank You!

    Here are the files you requested. For questions or additional information, contact busdev@crownbio.com or call +1 855-827-6968.

     

    Advances in Preclinical
    Modeling of
    NAFLD and NASH

    DoT_Presentation_TN.png

    The FATZO Mouse Model of
    Type 2 Diabetes Develops
    Non-Alcoholic Fatty
    Liver Disease (NAFLD)

    FATZO_NAFLD_Model_TN.png
    Hepatic Lipidosis and Fibrosis in Obese, Dysmetabolic, and Diabetic  Non-Human Primates Quantified by Noninvasive Sonography
    DoT_Sonography_TN.png
    map
    • Databases
    • HuBase
    • MuBase
    • XenoBase
    • Careers
    • Press
    • Terms of Use
    • Privacy Policy
    • Contact us
    • +1 855-827-6968
    • busdev@crownbio.com
    • Site map
    © 2021 Crown Bioscience Inc.